Search

Your search keyword '"Lu, Kan"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Lu, Kan" Remove constraint Author: "Lu, Kan"
225 results on '"Lu, Kan"'

Search Results

5. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

8. Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM

11. A tension-mediated glycocalyx–integrin feedback loop promotes mesenchymal-like glioblastoma

12. Highly efficient ultraviolet and visible light emissions from upconversion transitions in Ho/Tm/Yb co-doped lutecia-stabilized zirconia single crystals excited by a 980 nm laser.

16. Renal function is associated with 1-month and 1-year mortality in patients with ischemic stroke

17. Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

18. VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex

21. Cholesterol Levels Are Associated with 30-day Mortality from Ischemic Stroke in Dialysis Patients

22. Data from Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM

23. Supplementary Figure S1 from Mechanisms of Resistance to EGFR Inhibition Reveal Metabolic Vulnerabilities in Human GBM

24. Supplementary Figures 1 - 20 from Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

25. Supplementary Tables 1 - 6 from Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

26. Supplementary Figure Legend from Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

27. Supplementary Methods from Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance

29. Supplementary Methods and Materials from Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients

30. Data from Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients

31. Data from Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells

32. Supplementary Table 1 from Mammalian Target of Rapamycin Inhibition Promotes Response to Epidermal Growth Factor Receptor Kinase Inhibitors in PTEN-Deficient and PTEN-Intact Glioblastoma Cells

33. Supplementary Figures 1-6 from Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients

34. Gentiopicroside Ameliorated Ductular Reaction and Inflammatory Response in DDC-induced Murine Cholangiopathies Model

35. Derivation and Validation of a Discharge Disposition Predicting Model after Acute Stroke

36. Diversity and Innovation: Progress and Exploration of Domestic Art Movies in 2016

41. Discoidin Domain Receptor 1 Promotes Hepatocellular Carcinoma Progression through Modulation of SLC1A5 Expression

44. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors

49. miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5

Catalog

Books, media, physical & digital resources